Hem › Bröstcancer › Kalifornien › Mountain View
Kliniska studier för Bröstcancer i Mountain View, CA
26 studier för Bröstcancer söker deltagare vid platser i och runt Mountain View (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
RekryterarFas 3
- Stanford Women's Cancer Center, Palo Alto · 5 mi bort
A Study of PHST001 in Advanced Solid Tumors
RekryterarFas 1
- Stanford University School of Medicine, Palo Alto · 5 mi bort
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
RekryterarFas 3
- El Camino Hospital, Mountain View
- Palo Alto Medical Foundation, Mountain View
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
RekryterarFas 1/2
- Stanford Medicine Cancer Center, Stanford · 5 mi bort
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RekryterarFas 3
- El Camino Hospital Cancer Center ( Site 0096), Mountain View
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RekryterarFas 1
- Stanford University Medical Center, Stanford · 5 mi bort
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RekryterarFas 1
- Stanford University Medical Center, Stanford · 5 mi bort
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RekryterarFas 3
- Stanford Cancer Center, Palo Alto · 5 mi bort
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
RekryterarFas 3
- Stanford University School of Medicine - Stanford Cancer Institute (SCI) - Stanford Women's Cancer Center, Palo Alto · 5 mi bort
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekryterarFas 3
- Stanford Women's Cancer Center, Palo Alto · 5 mi bort
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
RekryterarFas 1
- Stanford University Hospital, Stanford · 5 mi bort
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
RekryterarFas 3
- Research Site, Palo Alto · 5 mi bort
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
RekryterarFas 2
- Stanford Cancer Institute, Palo Alto · 5 mi bort
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
RekryterarFas 3
- Palo Alto Medical Foundation Research Center, Palo Alto · 5 mi bort
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekryterarFas 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · 5 mi bort
- och 1 fler
Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer
RekryterarFas 2
- Stanford University, Stanford · 5 mi bort
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
RekryterarFas 2/3
- Local Institution - 0358, Stanford · 5 mi bort
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
RekryterarFas 3
- Stanford Medicine Cancer Center - Stanford Women's Cancer Center, Palo Alto · 5 mi bort
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
RekryterarFas 1
- Stanford University Medical Center, Palo Alto · 5 mi bort
Magnetic Resonance Imaging of Breast Cancer
RekryterarFriska volontärer välkomna
- Stanford University School of Medicine, Stanford · 5 mi bort
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
RekryterarObservationsstudie
- Stanford University School of Medicine, Stanford · 5 mi bort
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekryterarFas 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · 5 mi bort
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi bort
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
RekryterarFas 1
- Stanford Cancer Institute, Stanford · 5 mi bort
Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma
Rekryterar
- Stanford University, Stanford · 5 mi bort
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
RekryterarObservationsstudie
- Stanford Cancer Institute, Palo Alto · 5 mi bort
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, Stanford · 5 mi bort
Bröstcancer-studier i andra städer
- New York City, NY136 studier
- Houston, TX126 studier
- Boston, MA112 studier
- Nashville, TN81 studier
- Los Angeles, CA73 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Queens, NY64 studier
- Durham, NC64 studier
- Chicago, IL59 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
Andra studier i Mountain View
- Cancer (alla typer)40 studier
- Metastaserande cancer25 studier
- Icke-småcellig lungcancer21 studier
- Akut myeloid leukemi19 studier
- Äggstockscancer19 studier
- Autismspektrumstörning17 studier
- Lungcancer17 studier
- Prostatacancer15 studier
- Hjärtsvikt15 studier
- Autism13 studier
- Akut lymfoblastisk leukemi13 studier
- Kolorektal cancer13 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.